FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erik Fink Eriksen

Research Profile

Concepts & Ideas

Physiology

Anatomy

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Erik Fink Eriksen; Johan Halse; Mette Haase Moen
New developments in the treatment of osteoporosis.
Sara Salehi Hammerstad; Ingrid Norheim; Trond Paulsen; Lise Marit Amlie; Erik Fink Eriksen
Excessive decrease in serum magnesium after total thyroidectomy for Graves' disease is related to development of permanent hypocalcemia.
Erik Fink Eriksen
Treatment of osteopenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erik Fink Eriksen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Erik Fink Eriksen; Johan Halse; Mette Haase Moen
New developments in the treatment of osteoporosis.
Acta obstetricia et gynecologica Scandinavica 2013;92(6):620-36.
2013: Sara Salehi Hammerstad; Ingrid Norheim; Trond Paulsen; Lise Marit Amlie; Erik Fink Eriksen
Excessive decrease in serum magnesium after total thyroidectomy for Graves' disease is related to development of permanent hypocalcemia.
World journal of surgery 2013;37(2):369-75.
2012: Erik Fink Eriksen
Treatment of osteopenia.
Reviews in endocrine & metabolic disorders 2012;13(3):209-23.
2012: Erik Fink Eriksen; Johan Halse
[When should bisphosphonate treatment be discontinued?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2012;132(14):1630-2.
2012: Erik Fink Eriksen; Johan Diederich Ringe
Bone marrow lesions: a universal bone response to injury?
Rheumatology international 2012;32(3):575-84.
2012: Stine Marit Moen; Lars Nordsletten; Leiv Sandvik; Magritt Brustad; Elisabeth Gulowsen Celius; Erik Fink Eriksen; Trygve Holmøy
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.
PloS one 2012;7(9):e45703.
2011: Thomas Bøhmer; Erik Fink Eriksen
[Something to learn from--something to learn more from?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2011;131(22):2221; author reply 2221.
2011: Unni Syversen; Jürgen Geisler; Johan I Halse; Erik Fink Eriksen
[Denosumab for treatment of postmenopausal osteoporosis].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2011;131(19):1893-6.
2011: Felicia Cosman; Erik Fink Eriksen; Chris Recknor; Paul D Miller; Núria Guañabens; Christian Kasperk; Philemon Papanastasiou; Aimee Readie; Hanumantha Rao; Jürg A Gasser; Christina Bucci-Rechtweg; Steven Boonen
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(3):503-11.
2010: Erik Fink Eriksen
Cellular mechanisms of bone remodeling.
Reviews in endocrine & metabolic disorders 2010;11(4):219-27.
2010: Steven Boonen; Dennis M Black; Cathleen S Colón-Emeric; Ana Munoz; Jay Magaziner; Erik Fink Eriksen; Peter Mesenbrink; Patrick Haentjens; Kenneth W Lyles
Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.
Journal of the American Geriatrics Society 2010;58(2):292-9.
2009: Erik Fink Eriksen; Kenneth W Lyles; Cathleen S Colón-Emeric; Carl F Pieper; Jay Magaziner; Jonathan D Adachi; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Catherine Lavecchia; Huilin Hu; Steven Boonen; Peter Mesenbrink
Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(7):1308-13.
2009: Erik Fink Eriksen
[Osteonecrosis of the jaw].
Ugeskrift for laeger 2009;171(8):629; author reply 629.
2008: René Rizzoli; Nansa Burlet; David Cahall; Pierre D Delmas; Erik Fink Eriksen; Dieter Felsenberg; John Grbic; Mats Jontell; Regina Landesberg; Andrea Laslop; Martina Wollenhaupt; Socrates Papapoulos; Orhan Sezer; Michael Sprafka; Jean-Yves Reginster
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
Bone 2008;42(5):841-7.
2008: John T Grbic; Regina Landesberg; Shou-qing Lin; Peter Mesenbrink; Ian R Reid; Ping-Chung Leung; Noemi Casas; Christopher P Recknor; Ye Hua; Pierre D Delmas; Erik Fink Eriksen
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Journal of the American Dental Association (1939) 2008;139(1):32-40.
2008: Robert R Recker; Pierre D Delmas; Johan Halse; Ian R Reid; Steven Boonen; Pedro A García-Hernandez; Jerzy Supronik; E Michael Lewiecki; Luis Ochoa; Paul Miller; Huilin Hu; Peter Mesenbrink; Florian Hartl; Juerg Gasser; Erik Fink Eriksen
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(1):6-16.
2007: Kenneth W Lyles; Cathleen S Colón-Emeric; Jay Magaziner; Jonathan D Adachi; Carl F Pieper; Carlos Mautalen; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Kathy A Moore; Catherine Lavecchia; Jie Zhang; Peter Mesenbrink; Patricia K Hodgson; Ken Abrams; John J Orloff; Zebulun Horowitz; Erik Fink Eriksen; Steven Boonen
Zoledronic acid and clinical fractures and mortality after hip fracture.
The New England journal of medicine 2007;357(18):1799-809.
2007: Jean-Pierre Devogelaer; Jacques P Brown; Peter Burckhardt; P J Meunier; Stefan Goemaere; Kurt Lippuner; Jean-Jacques Body; G Samsioe; Dieter Felsenberg; Taiwo Fashola; L Sanna; C E Ortmann; Ulrich Trechsel; J Krasnow; Erik Fink Eriksen; P Garnero
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(9):1211-8.
2007: Dennis M Black; Pierre D Delmas; Ana Munoz; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Elaine Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
The New England journal of medicine 2007;356(18):1809-22.
2007: Richard Weitzman; Nicholas Sauter; Erik Fink Eriksen; Peter G Tarassoff; Leo V Lacerna; Rosh Dias; Anne Altmeyer; Katalin Csermak-Renner; Lynne McGrath; Linda Lantwicki; John A Hohneker
Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.
Critical reviews in oncology/hematology 2007;62(2):148-52.
2007: Erik Fink Eriksen; Guiti Z Eghbali-Fatourechi; Sundeep Khosla
Remodeling and vascular spaces in bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(1):1-6.
2007: David Hosking; Kenneth W Lyles; Jacques P Brown; William D Fraser; Paul Miller; Manuel Diaz Curiel; Jean-Pierre Devogelaer; Michael Hooper; Guoqin Su; Ken Zelenakas; Judy Pak; Taiwo Fashola; Youssef Saidi; Erik Fink Eriksen; Ian R Reid
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(1):142-8.
2007: Harry K Genant; P D Delmas; P Chen; Yebin Jiang; Erik Fink Eriksen; Gail P Dalsky; R Marcus; Javier A San Martin
Severity of vertebral fracture reflects deterioration of bone microarchitecture.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(1):69-76.
2006: Yanfei L Ma; Qingqiang Zeng; David W Donley; Louis-Georges Ste-Marie; J Christopher Gallagher; Gail P Dalsky; Robert Marcus; Erik Fink Eriksen
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(6):855-64.
2005: Chad Deal; Molly Omizo; Elliott N Schwartz; Erik Fink Eriksen; Per Cantor; Jingyuan Wang; Emmett Glass; Stephen L Myers; John Krege
Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(11):1905-11.
2005: Charles H Chesnut; Sharmila Majumdar; David Newitt; Andrew Shields; Jan Van Pelt; Ellen Laschansky; Moïse Azria; Audrey Kriegman; Melvin Olson; Erik Fink Eriksen; Linda Mindeholm
Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(9):1548-61.
2005: Michael R McClung; Javier A San Martin; Paul D Miller; Roberto Civitelli; Francisco Bandeira; Molly Omizo; David W Donley; Gail P Dalsky; Erik Fink Eriksen
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
Archives of internal medicine 2005;165(15):1762-8.
2005: Eleftherios P Paschalis; Emmett Glass; David W Donley; Erik Fink Eriksen
Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial.
The Journal of clinical endocrinology and metabolism 2005;90(8):4644-9.
2005: Monique Arlot; Pierre J Meunier; Georges Boivin; Lillian Haddock; Juan Tamayo; Ricardo Correa-Rotter; Salomón Jasqui; David W Donley; Gail P Dalsky; Javier San Martin; Erik Fink Eriksen
Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(7):1244-53.
2005: Harald Dobnig; Adrien Sipos; Yebin Jiang; Astrid Fahrleitner-Pammer; Louis-Georges Ste-Marie; J Christopher Gallagher; Imre Pavo; Jingyuan Wang; Erik Fink Eriksen
Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
The Journal of clinical endocrinology and metabolism 2005;90(7):3970-7.
2005: Kirsti Uusi-Rasi; LISA REIDER; Jose R Zanchetta; Cesar E Bogado; Erik Fink Eriksen; Masahiko Sato; Thomas J Beck
Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.
Bone 2005;36(6):948-58.
2004: Erik Fink Eriksen; Deborah A Robins
Teriparatide: A bone formation treatment for osteoporosis.
Drugs of today (Barcelona, Spain : 1998) 2004;40(11):935-48.
2004: Lis Stilgren; E Rettmer; Erik Fink Eriksen; Laszlo Hegedüs; Henning Beck-Nielsen; Bo Abrahamsen
Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Bone 2004;35(1):256-65.
2004: P Monica Lind; Erik Fink Eriksen; Lars Lind; Jan Orberg; Lena Sahlin
Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Toxicology 2004;199(2-3):129-36.
2004: Niels Abildgaard; Kim Brixen; Erik Fink Eriksen; Jens Erik Kristensen; Johan Lanng Nielsen; Lene Heickendorff
Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
Haematologica 2004;89(5):567-77.
2004: Henning Glerup; Erik Fink Eriksen
[D-vitamin: old paradoxes and new perspectives].
Ugeskrift for laeger 2004;166(1-2):36-40.
2003: Yebin Jiang; Jenny J Zhao; Bruce H Mitlak; Ouhong Wang; Harry K Genant; Erik Fink Eriksen
Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(11):1932-41.
2003: Mathias H Bünger; Bente Langdahl; T Andersen; L Husted; Martin Lind; Erik Fink Eriksen; Cody E Bünger
Semiquantitative mRNA measurements of osteoinductive growth factors in human iliac-crest bone: expression of LMP splice variants in human bone.
Calcified tissue international 2003;73(5):446-54.
2003: Bente Langdahl; Liselotte Stenkjaer; Mette Carstens; Charlotte Landbo Tofteng; Erik Fink Eriksen
A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
Calcified tissue international 2003;73(3):237-43.
2003: Eleftherios P Paschalis; Adele L Boskey; M Kassem; Erik Fink Eriksen
Effect of hormone replacement therapy on bone quality in early postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):955-9.
2003: H Andersen; O N Jensen; Erik Fink Eriksen
A proteome study of secreted prostatic factors affecting osteoblastic activity: identification and characterisation of cyclophilin A.
European journal of cancer (Oxford, England : 1990) 2003;39(7):989-95.
2003: Bente Langdahl; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.
Bone 2003;32(3):297-310.
2003: Niels Abildgaard; Kim Brixen; Jens Erik Kristensen; Erik Fink Eriksen; Johan Lanng Nielsen; Lene Heickendorff
Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy.
British journal of haematology 2003;120(2):235-42.
2002: Erik Fink Eriksen; Flemming Melsen; E Sod; Ian P Barton; AA Chines
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis.
Bone 2002;31(5):620-5.
2002: Erik Fink Eriksen
Primary hyperparathyroidism: lessons from bone histomorphometry.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17 Suppl 2():N95-7.
2002: Bente Langdahl; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(7):1245-55.
2002: Niklas Rye Jorgensen; Zanne Henriksen; Ole Helmer Sørensen; Erik Fink Eriksen; Roberto Civitelli; Thomas H Steinberg
Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors.
The Journal of biological chemistry 2002;277(9):7574-80.
2002: Erik Fink Eriksen; Henning Glerup
Vitamin D deficiency and aging: implications for general health and osteoporosis.
Biogerontology 2002;3(1-2):73-7.
2001: EM Hauge; D Qvesel; Erik Fink Eriksen; Leif Mosekilde; Flemming Melsen
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(9):1575-82.
2001: Robert M Neer; C D Arnaud; Jose R Zanchetta; Richard Prince; Gregory A Gaich; Jean-Yves Reginster; Anthony B Hodsman; Erik Fink Eriksen; Sophia Ish-Shalom; Harry K Genant; Ouhong Wang; Bruce H Mitlak
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
The New England journal of medicine 2001;344(19):1434-41.
2001: Steven T Harris; Erik Fink Eriksen; M Davidson; Mark P Ettinger; A H Moffett Jr; David J Baylink; C E Crusan; AA Chines
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
The Journal of clinical endocrinology and metabolism 2001;86(5):1890-7.
2000: M Wolf; Wa'el El-Rifai; Maija Tarkkanen; Juha Kononen; M Serra; Erik Fink Eriksen; Inkeri Elomaa; Anne Kallioniemi; Olli Kallioniemi; Sakari Knuutila
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray.
Cancer genetics and cytogenetics 2000;123(2):128-32.
2000: Bente Langdahl; E Løkke; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(11):2222-30.
2000: Bente Langdahl; Claus Gravholt; Kim Brixen; Erik Fink Eriksen
Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures.
European journal of clinical investigation 2000;30(7):608-17.
2000: Niklas Rye Jorgensen; Zanne Henriksen; C Brot; Erik Fink Eriksen; Ole Helmer Sørensen; Roberto Civitelli; Thomas H Steinberg
Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(6):1024-32.
2000: Henning Glerup; K Mikkelsen; L Poulsen; E Hass; S Overbeck; H Andersen; P Charles; Erik Fink Eriksen
Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement.
Calcified tissue international 2000;66(6):419-24.
2000: Bente Langdahl; E Løkke; Mette Carstens; Liselotte Stenkjaer; Erik Fink Eriksen
Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(3):402-14.
2000: Niels Abildgaard; Henning Glerup; J Rungby; K Bendix-Hansen; M Kassem; Kim Brixen; Lene Heickendorff; Johan Lanng Nielsen; Erik Fink Eriksen
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
European journal of haematology 2000;64(2):121-9.
2000: Henning Glerup; K Mikkelsen; L Poulsen; E Hass; S Overbeck; J Thomsen; P Charles; Erik Fink Eriksen
Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited.
Journal of internal medicine 2000;247(2):260-8.
2000: Bo Abrahamsen; V Shalhoub; EK Larson; Erik Fink Eriksen; Henning Beck-Nielsen; Sandy C Marks
Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.
Bone 2000;26(2):137-45.
2000: C G Carlsen; T H Soerensen; Erik Fink Eriksen
Prevalence of low serum estradiol levels in male osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(8):697-701.
1999: Steven T Harris; Nelson B Watts; Harry K Genant; C D McKeever; T Hangartner; M Keller; Charles H Chesnut; J Brown; Erik Fink Eriksen; MS Hoseyni; D W Axelrod; Paul D Miller
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
JAMA : the journal of the American Medical Association 1999;282(14):1344-52.
1999: Erik Fink Eriksen; Bente Langdahl; A Vesterby; J Rungby; M Kassem
Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(7):1217-21.
1999: Henning Glerup; Erik Fink Eriksen
Acroparaesthesia--a typical finding in vitamin D deficiency.
Rheumatology (Oxford, England) 1999;38(5):482.
1999: Henning Glerup; Erik Fink Eriksen
[Vitamin D deficiency. Easy to diagnose, often overlooked].
Ugeskrift for laeger 1999;161(17):2515-21.
1999: Henning Glerup; Erik Fink Eriksen
[Polyneuropathies].
Ugeskrift for laeger 1999;161(8):1133-4.
1999: P Monica Lind; Erik Fink Eriksen; L Sahlin; Måns Gustaf Edlund; Jan Orberg
Effects of the antiestrogenic environmental pollutant 3,3',4,4', 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Toxicology and applied pharmacology 1999;154(3):236-44.
1998: Bente Langdahl; S H Ralston; S F Grant; Erik Fink Eriksen
An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(9):1384-9.
1998: Niels Abildgaard; J Rungby; Henning Glerup; Kim Brixen; M Kassem; H Brincker; Lene Heickendorff; Erik Fink Eriksen; Johan Lanng Nielsen
Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma.
European journal of haematology 1998;61(2):128-34.
1998: Bente Langdahl; Erik Fink Eriksen
The influence of thyroid hormones on bone turnover in health and osteopetrosis.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(1):10-1.
1998: Charlotte Albjerg Ejersted; Hans Oxlund; Erik Fink Eriksen; Troels T Andreassen
Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats.
Bone 1998;23(1):43-52.
1998: Bente Langdahl; M Kassem; M K Møller; Erik Fink Eriksen
The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone.
European journal of clinical investigation 1998;28(3):176-83.
1998: Erik Fink Eriksen
[Osteoporosis--when medical treatment is necessary].
Sygeplejersken 1998;98(6):22-7.
1998: Kim Brixen; Thomas B Hansen; Erik Fink Eriksen; Leif Mosekilde
Does growth hormone therapy in adult patients with growth hormone deficiency protect against bone loss?
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8 Suppl A():81-6.
1997: AG Johansson; Erik Fink Eriksen; E Lindh; B Langdahl; WF Blum; A Lindahl; Osten Ljunggren; Sverker Ljunghall
Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men.
The Journal of clinical endocrinology and metabolism 1997;82(9):2795-8.
1997: Bente Langdahl; J Y Knudsen; H K Jensen; N Gregersen; Erik Fink Eriksen
A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women.
Bone 1997;20(3):289-94.
1997: Ole Helmer Sørensen; Stig Pors Nielsen; P Charles; Erik Fink Eriksen; Leif Mosekilde; R P Heaney; J Falch; Johan Halse; E Haug
Consensus development statement on osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(6):589.
1997: M Kassem; L Ankersen; Erik Fink Eriksen; B F Clark; S I Rattan
Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(6):514-24.
1997: Erik Fink Eriksen; Bente Langdahl
The pathogenesis of osteoporosis.
Hormone research 1997;48 Suppl 5():78-82.
1997: Bente Langdahl; A G Loft; Niels Møller; Jørgen Weeke; Erik Fink Eriksen; Leif Mosekilde; P Charles
Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(1):78-88.
1996: Erik Fink Eriksen; Moustapha Kassem; Bente Langdahl
European and North American Experience with HRT for the prevention of osteoporosis.
Bone 1996;19(5 Suppl):179S-183S.
1996: Bente Langdahl; A G Loft; N Møller; J Weeke; Erik Fink Eriksen; Leif Mosekilde; P Charles
Skeletal responsiveness to thyroid hormone is not altered at menopause.
Bone 1996;19(5):557-64.
1996: Erik Fink Eriksen; Moustapha Kassem; Bente Langdahl
Growth hormone, insulin-like growth factors and bone remodelling.
European journal of clinical investigation 1996;26(7):525-34.
1996: Bente Langdahl; A G Loft; Erik Fink Eriksen; Leif Mosekilde; P Charles
Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
Thyroid : official journal of the American Thyroid Association 1996;6(3):169-75.
1996: Bente Langdahl; A G Loft; Erik Fink Eriksen; Leif Mosekilde; P Charles
Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy.
Thyroid : official journal of the American Thyroid Association 1996;6(3):161-8.
1996: Bente Langdahl; A G Loft; Erik Fink Eriksen; Leif Mosekilde; P Charles
Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 1996;134(6):702-9.
1996: R W Boyce; C L Paddock; A F Franks; M L Jankowsky; Erik Fink Eriksen
Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996;11(5):600-13.
1996: Bente Langdahl; L Mortensen; A Vesterby; Erik Fink Eriksen; P Charles
Bone histomorphometry in hypoparathyroid patients treated with vitamin D.
Bone 1996;18(2):103-8.
1996: M LInd; Erik Fink Eriksen; C Bünger
Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells.
Bone 1996;18(1):53-7.
1995: Erik Fink Eriksen; Bente Langdahl
Bone changes in metabolic bone disease.
Acta orthopaedica Scandinavica. Supplementum 1995;266():195-201.
1995: Erik Fink Eriksen; Kim Brixen; P Charles
New markers of bone metabolism: clinical use in metabolic bone disease.
European journal of endocrinology / European Federation of Endocrine Societies 1995;132(3):251-63.
1995: R W Boyce; C L Paddock; J R Gleason; W K Sletsema; Erik Fink Eriksen
The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(2):211-21.
1995: Martin Lind; Bent Deleuran; K Thestrup-Pedersen; K Søballe; Erik Fink Eriksen; C Bünger
Chemotaxis of human osteoblasts. Effects of osteotropic growth factors.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1995;103(2):140-6.
1994: Moustapha Kassem; X Zhang; S Brask; Erik Fink Eriksen; Leif Mosekilde; T A Kruse
Familial isolated primary hyperparathyroidism.
Clinical endocrinology 1994;41(4):415-20.
1994: Ole Helmer Sørensen; Stig Pors Nielsen; J Thode; Erik Fink Eriksen
[Osteoporosis-profile--a bad examination?].
Ugeskrift for laeger 1994;156(38):5503-5.
1994: H Glerup; Erik Fink Eriksen; Leif Mosekilde
[Glucocorticoid-induced osteopenia].
Ugeskrift for laeger 1994;156(38):5489-94.
1994: M Kassem; Leif Mosekilde; Erik Fink Eriksen
Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro.
Growth regulation 1994;4(3):131-5.
1994: Moustapha Kassem; Kim Brixen; Werner Blum; Leif Mosekilde; Erik Fink Eriksen
Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(9):1365-70.
1994: Moustapha Kassem; Kim Brixen; W Blum; Leif Mosekilde; Erik Fink Eriksen
No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis.
European journal of endocrinology / European Federation of Endocrine Societies 1994;131(2):150-5.
1994: M Kassem; Leif Mosekilde; Erik Fink Eriksen
Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(4):381-6.
1994: P Charles; Leif Mosekilde; Leila Risteli; J Risteli; Erik Fink Eriksen
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics.
Bone and mineral 1994;24(2):81-94.
1994: L Ankersen; M Kassem; L H Ostergaard; Erik Fink Eriksen; B F Clark; S I Rattan
Aging of human trabecular osteoblasts in culture.
Archives of gerontology and geriatrics 1994;19 Suppl 1():5-12.
1994: Moustapha Kassem; Kim Brixen; Leif Mosekilde; Erik Fink Eriksen
Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis.
Calcified tissue international 1994;54(1):1-6.
1993: Moustapha Kassem; Leif Mosekilde; Erik Fink Eriksen
1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8(12):1453-8.
1993: S F Hodgson; E R Dickson; R Eastell; Erik Fink Eriksen; S C Bryant; Lawrence B. Riggs
Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis.
Bone 1993;14(6):819-27.
1993: Moustapha Kassem; Leif Mosekilde; Erik Fink Eriksen
Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro.
Biochemistry and molecular biology international 1993;30(4):779-88.
1993: H Brockstedt; Moustapha Kassem; Erik Fink Eriksen; Leif Mosekilde; F Melsen
Age- and sex-related changes in iliac cortical bone mass and remodeling.
Bone 1993;14(4):681-91.
1993: J Rungby; Moustapha Kassem; Erik Fink Eriksen; Gorm Danscher
The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background.
The Histochemical journal 1993;25(6):446-51.
1993: Erik Fink Eriksen
Assessment of erosion depth by lamellar counting.
Bone 1993;14(3):443-7.
1993: Erik Fink Eriksen; H Kudsk; K Emmertsen; Leif Mosekilde; F Melsen
Bone remodeling during calcitonin excess: reconstruction of the remodeling sequence in medullary thyroid carcinoma.
Bone 1993;14(3):399-401.
1993: Moustapha Kassem; W Blum; J Ristelli; Leif Mosekilde; Erik Fink Eriksen
Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro.
Calcified tissue international 1993;52(3):222-6.
1993: Erik Fink Eriksen; P Charles; F Melsen; Leif Mosekilde; Leila Risteli; J Risteli
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8(2):127-32.
1993: Kim Brixen; Moustapha Kassem; Erik Fink Eriksen; H K Nielsen; A Flyvbjerg; Leif Mosekilde
Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis.
The Journal of pediatric endocrinology 1993;6(1):65-71.
1993: Erik Fink Eriksen; Moustapha Kassem; Kim Brixen
Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis.
Hormone research 1993;40(1-3):95-8.
1992: P Charles; C Hasling; Leila Risteli; J Risteli; Leif Mosekilde; Erik Fink Eriksen
Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.
Calcified tissue international 1992;51(6):406-11.
1992: Erik Fink Eriksen; F Melsen; Leif Mosekilde
Histomorphometric analysis of resorption and formation in osteoporotics and controls with a mean age of 61 years.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(8):999-1002.
1992: Moustapha Kassem; J Rungby; Leif Mosekilde; Erik Fink Eriksen
Ultrastructure of human osteoblasts and associated matrix in culture.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1992;100(6):490-7.
1992: T Steiniche; Erik Fink Eriksen; H Kudsk; Leif Mosekilde; F Melsen
Reconstruction of the formative site in trabecular bone by a new, quick, and easy method.
Bone 1992;13(2):147-52.
1991: C Hasling; Erik Fink Eriksen; J Melkko; Leila Risteli; P Charles; Leif Mosekilde; J Risteli
Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(12):1295-300.
1991: S Bisballe; Erik Fink Eriksen; F Melsen; Leif Mosekilde; O H Sørensen; I Hessov
Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.
Gut 1991;32(11):1303-7.
1991: P Charles; Erik Fink Eriksen; C Hasling; K Søndergård; Leif Mosekilde
Dermal, intestinal, and renal obligatory losses of calcium: relation to skeletal calcium loss.
The American journal of clinical nutrition 1991;54(1 Suppl):266S-273S.
1991: Steen Pedersen; Jens Børglum; Erik Fink Eriksen; Bjørn Richelsen
Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones.
Biochimica et biophysica acta 1991;1093(1):80-6.
1991: Moustapha Kassem; Leila Risteli; Leif Mosekilde; F Melsen; Erik Fink Eriksen
Formation of osteoblast-like cells from human mononuclear bone marrow cultures.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1991;99(3):269-74.
1991: Moustapha Kassem; L Mosekilde; J Rungby; Leif Mosekilde; F Melsen; Erik Fink Eriksen
Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1991;99(3):262-8.
1991: M Kassem; Erik Fink Eriksen; F Melsen; Leif Mosekilde
Antacid-induced osteomalacia: a case report with a histomorphometric analysis.
Journal of internal medicine 1991;229(3):275-9.
1991: M O Agerbaek; Erik Fink Eriksen; J Kragstrup; L Mosekilde; F Melsen
A reconstruction of the remodelling cycle in normal human cortical iliac bone.
Bone and mineral 1991;12(2):101-12.
1991: M Kassem; Erik Fink Eriksen; L Mosekilde
[Familial hypercalciuric hypercalcemia].
Nordisk medicin 1991;106(4):107-8, 111.
1991: T Steiniche; C Hasling; P Charles; Erik Fink Eriksen; Flemming Melsen; Leif Mosekilde
The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime.
Bone 1991;12(3):155-63.
1991: L Mosekilde; Erik Fink Eriksen; P Charles
Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
Critical reviews in oncology/hematology 1991;11(1):1-27.
1990: M A Kotowicz; G G Klee; P C Kao; W Michael O'Fallon; S F Hodgson; S L Cedel; Erik Fink Eriksen; D G Gonchoroff; HL Judd; Lawrence B. Riggs
Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: evidence that skeletal sensitivity is increased.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1990;1(1):14-22.
1990: Erik Fink Eriksen; S F Hodgson; Ana Munoz; S L Cedel; W Michael O'Fallon; Lawrence B. Riggs
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(4):311-9.
1990: L Mosekilde; Erik Fink Eriksen; P Charles
Effects of thyroid hormones on bone and mineral metabolism.
Endocrinology and metabolism clinics of North America 1990;19(1):35-63.
1989: Erik Fink Eriksen; T Steiniche; Leif Mosekilde; F Melsen
Histomorphometric analysis of bone in metabolic bone disease.
Endocrinology and metabolism clinics of North America 1989;18(4):919-54.
1989: K Thomsen; Erik Fink Eriksen; J C Jørgensen; P Charles; L Mosekilde
Seasonal variation of serum bone GLA protein.
Scandinavian journal of clinical and laboratory investigation 1989;49(7):605-11.
1989: D S Colvard; Erik Fink Eriksen; P E Keeting; Elizabeth M Wilson; D B Lubahn; Frank S French; Lawrence B. Riggs; Thomas C Spelsberg
Identification of androgen receptors in normal human osteoblast-like cells.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(3):854-7.
1989: Kim Brixen; H K Nielsen; Erik Fink Eriksen; P Charles; L Mosekilde
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein.
Calcified tissue international 1989;44(2):93-8.
1989: Erik Fink Eriksen; F Melsen; L Mosekilde
[Hormonal regulation of bone remodeling].
Nordisk medicin 1989;104(4):108-11.
1989: T Steiniche; C Hasling; P Charles; Erik Fink Eriksen; Leif Mosekilde; Flemming Melsen
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
Bone 1989;10(5):313-20.
1988: James L. Borke; Erik Fink Eriksen; J Minami; P Keeting; K G Mann; John Penniston; Lawrence B. Riggs; Rajiv Kumar
Epitopes of the human erythrocyte Ca2+-Mg2+ ATPase pump in human osteoblast-like cell plasma membranes.
The Journal of clinical endocrinology and metabolism 1988;67(6):1299-304.
1988: Ana Munoz; P D Delmas; S F Hodgson; Erik Fink Eriksen; K G Mann; Lawrence B. Riggs
Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers.
The Journal of clinical endocrinology and metabolism 1988;67(4):741-8.
1988: H J Donahue; M J Fryer; Erik Fink Eriksen; H Heath
Differential effects of parathyroid hormone and its analogues on cytosolic calcium ion and cAMP levels in cultured rat osteoblast-like cells.
The Journal of biological chemistry 1988;263(27):13522-7.
1988: Erik Fink Eriksen; D S Colvard; N J Berg; Mark Graham II; K G Mann; Thomas C Spelsberg; Lawrence B. Riggs
Evidence of estrogen receptors in normal human osteoblast-like cells.
Science (New York, N.Y.) 1988;241(4861):84-6.
1988: H K Nielsen; K Thomsen; Erik Fink Eriksen; P Charles; T Storm; L Mosekilde
The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Bone and mineral 1988;4(1):105-13.
1988: H K Nielsen; Erik Fink Eriksen; T Storm; L Mosekilde
The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects.
Metabolism: clinical and experimental 1988;37(2):109-14.
1987: P Charles; Erik Fink Eriksen; L Mosekilde; F Melsen; F T Jensen
Bone turnover and balance evaluated by a combined calcium balance and 47calcium kinetic study and dynamic histomorphometry.
Metabolism: clinical and experimental 1987;36(12):1118-24.
1987: Erik Fink Eriksen; Bjørn Richelsen; Borbala Gesser; N O Jacobsen; K Stengaard-Pedersen
Prostaglandin-E2 receptors in the rat kidney: biochemical characterization and localization.
Kidney international 1987;32(2):181-6.
1987: C Hasling; Erik Fink Eriksen; P Charles; L Mosekilde
Exogenous triiodothyronine activates bone remodeling.
Bone 1987;8(2):65-9.
1987: O F Petersen; M Buhl; Erik Fink Eriksen; K Fode; A Klaerke; L Krøyer; H Lindeberg; C B Madsen; T Miletic; P Strange
The significance of preoperative radiological examinations in patients treated with Cloward's operation.
Acta neurochirurgica 1987;88(1-2):39-45.
1987: J O Espersen; A Klaerke; M Buhl; Erik Fink Eriksen; K Fode; L Krøyer; H Lindeberg; C B Madsen; P Strange; L Wohlert
Treatment of cervical disc disease using Cloward's technique. Part V. The effect of reoperations.
Acta neurochirurgica 1987;88(1-2):34-8.
1986: L Mosekilde; P Charles; Erik Fink Eriksen; C Hasling; F Melsen
[Treatment with sodium fluoride, calcium phosphate and vitamin D2 in spinal osteoporosis. Effect on calcium balance, calcium metabolism, bone remodelling, and side effects].
Ugeskrift for laeger 1986;148(51):3449-53.
1986: Erik Fink Eriksen
Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease.
Endocrine reviews 1986;7(4):379-408.
1986: Erik Fink Eriksen; H K Nielsen; L Mosekilde; H B Nielsen; F Melsen
Nuclear uptake of 1,25-dihydroxy[3H]-cholecalciferol in peripheral blood monocytes.
Scandinavian journal of immunology 1986;24(2):171-7.
1986: Erik Fink Eriksen; L Mosekilde; F Melsen
Trabecular bone remodeling and balance in primary hyperparathyroidism.
Bone 1986;7(3):213-21.
1986: T Steiniche; A Vesterby; Erik Fink Eriksen; Leif Mosekilde; Flemming Melsen
A histomorphometric determination of iliac bone structure and remodeling in obese subjects.
Bone 1986;7(2):77-82.
1986: Erik Fink Eriksen; L Mosekilde; F Melsen
Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle.
Bone 1986;7(2):101-8.
1985: Erik Fink Eriksen; B Richelsen; H Beck-Nielsen; F Melsen; H K Nielsen; L Mosekilde
Prostaglandin E2 receptors on human peripheral blood monocytes.
Scandinavian journal of immunology 1985;21(2):167-72.
1985: Erik Fink Eriksen; L Mosekilde; F Melsen
Trabecular bone remodeling and bone balance in hyperthyroidism.
Bone 1985;6(6):421-8.
1985: Erik Fink Eriksen; L Mosekilde; F Melsen
Trabecular bone resorption depth decreases with age: differences between normal males and females.
Bone 1985;6(3):141-6.
1984: H Danielsen; Erik Fink Eriksen; A Johansen; J Sølling
Serum immunoglobulin sedimentation patterns and circulating immune complexes in IgA glomerulonephritis and Schönlein-Henoch nephritis.
Acta medica Scandinavica 1984;215(5):435-41.
1981: Erik Fink Eriksen; H Danielsen; R Brodersen
Bilirubin-liposome interaction. Binding of bilirubin dianion, protonization, and aggregation of bilirubin acid.
The Journal of biological chemistry 1981;256(9):4269-74.
1981: Erik Fink Eriksen; L I Larsson
Neuropeptides in the retina: evidence for differential topographical localization.
Peptides 1981;2(2):153-7.